Issue 6, 2025

Itaconate and its derivatives as anti-pathogenic agents

Abstract

Pathogenic microorganisms and viruses cause outbreaks and pandemics that affect millions of people worldwide. Despite recent advances in pharmacology and medicine, the ability of infectious diseases to spread in the modern era is accelerating due to various factors contributing to increased human-to-human and human–animal contacts. With the global rise of drug resistance among pathogens and frequently occurring viral outbreaks, alternative drugs and therapies that specifically inhibit microbial virulence or regulate immune responses are attracting growing interest. The present review focuses on itaconate and its derivatives as potential anti-pathogenic agents. It summarizes the current state of research on itaconate metabolism in bacteria, fungi and mammals. This is followed by a comprehensive review of recent advances studying itaconate and its derivatives as anti-inflammatory, immunoregulatory, antimicrobial and antiviral compounds, along with their mechanisms of action. Finally, the review emphasises the existing challenges and future research directions for the application of itaconate and its derivatives as anti-pathogenic agents.

Graphical abstract: Itaconate and its derivatives as anti-pathogenic agents

Article information

Article type
Review Article
Submitted
22 Nov 2024
Accepted
24 Jan 2025
First published
10 Feb 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 4408-4420

Itaconate and its derivatives as anti-pathogenic agents

R. Al Akiki Dit Al Mazraani, N. Malys and V. Maliene, RSC Adv., 2025, 15, 4408 DOI: 10.1039/D4RA08298B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements